Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial Article

sustainable development goals

publication date

  • September 17, 2016

webpage

published in

start page

  • 1183

end page

  • 1192

volume

  • 388

issue

  • 10050